1174415-90-7

1174415-90-7 structure

Name: Onvitrelin ucalontide
Chemical Name: Onvitrelin ucalontide
CAS Number: 1174415-90-7
Molecular Formula: C₁₆₃H₂₄₃N₄₃O₃₂
Molecular Weight: 3316.94
Catalog: Signaling Pathways GPCR/G Protein GNRH Receptor
Create Date: 2023-04-10 20:37:26
Modify Date: 2024-02-04 05:37:01
Onvitrelin ucalontide ([Phor18-LHRH (338613)]) is an analogue of luteinizing hormone releasing hormone (LHRH) with antineoplastic activity. Onvitrelin ucalontide is a peptide with sequences of KFAKFAKKFAKFAKKFAKQHWSYGLRPG. Onvitrelin ucalontide effectively inhibits breast cancer, ovarian cancer and prostate cancer xenografts in mouse model[1][2].

Name	Onvitrelin ucalontide

Description	Onvitrelin ucalontide ([Phor18-LHRH (338613)]) is an analogue of luteinizing hormone releasing hormone (LHRH) with antineoplastic activity. Onvitrelin ucalontide is a peptide with sequences of KFAKFAKKFAKFAKKFAKQHWSYGLRPG. Onvitrelin ucalontide effectively inhibits breast cancer, ovarian cancer and prostate cancer xenografts in mouse model[1][2].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> GNRH Receptor Research Areas >> Cancer Research Areas >> Endocrinology
References	[1]. Leuschner Carola, et al. Lytic domain fusion constructs and methods of making and using same for treating cell proliferation disorders: World Intellectual Property Organization, WO2009094634. 2009-07-30. [2]. WHO Drug Information-World Health Organization (WHO).

Molecular Formula	C₁₆₃H₂₄₃N₄₃O₃₂
Molecular Weight	3316.94